<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="24289">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02790554</url>
  </required_header>
  <id_info>
    <org_study_id>Moyo Urban</org_study_id>
    <nct_id>NCT02790554</nct_id>
  </id_info>
  <brief_title>Moyo; strap-on Fetal Heart Rate Monitoring in an Urban Setting</brief_title>
  <official_title>Evaluation of an Innovative Fetal Heart Rate Monitoring Device (Named Moyo) to Improve Perinatal Outcome in Dar es Salaam, Tanzania</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helse Stavanger HF</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helse Stavanger HF</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Annually, an estimated 2.6 million still births occur half of which die during labor and
      delivery (fresh stillbirths). In addition, around 750,000 newborns die shortly after birth
      due to intrapartum-related hypoxia or birth asphyxia. Almost 99% of these perinatal deaths
      take place in low-income countries where the provider/patient ratio is low and fetal
      monitoring is inadequate. Poor intrapartum fetal heart rate monitoring, failure to identify
      fetal distress, and subsequently intervene, is a common pathway to perinatal deaths in these
      low-resourced settings. Recently, an innovative fetal heart rate monitoring device, called
      Moyo, using ultrasound technology, was developed to be strapped on the mother during labour.
      This project will compare the effectiveness of automatic use of Moyo versus intermittent use
      of hand-held Doppler in detection of abnormal fetal heart rate, through a randomized control
      study, at the University hospital, Dar es Salaam, Tanzania.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">April 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Frequency of abnormal fetal heart rate detection</measure>
    <time_frame>Up to delivery</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mode of delivery: vaginal versus operative</measure>
    <time_frame>Up to delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time interval from abnormal fetal heart rate detection to delivery in minutes</measure>
    <time_frame>Up to delivery</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neonatal outcome dead versus alive</measure>
    <time_frame>Up to 24 hours</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Fetal Monitoring</condition>
  <arm_group>
    <arm_group_label>Moyo strap-on</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continous fetal heart rate monitoring</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hand-held Doppler</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intermittent fetal heart rate monitoring</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Moyo strap-on</intervention_name>
    <description>Continous monitoring</description>
    <arm_group_label>Moyo strap-on</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Hand-held Doppler</intervention_name>
    <description>Intermittent monitoring</description>
    <arm_group_label>Hand-held Doppler</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women admitted in labor

        Exclusion Criteria:

          -  Women scheduled for elective cesarean section, women with abnormal fetal heart rate
             on admission, multiples, and critically ill patients with no measurements of fetal
             heart rate on admission
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hege L. Ersdal, Md PhD</last_name>
    <role>Study Director</role>
    <affiliation>Stavanger University Hospital, Norway</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hege L Ersdal, MD, PhD</last_name>
    <phone>99647822</phone>
    <phone_ext>+47</phone_ext>
    <email>hege.ersdal@safer.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Muhimbili National Hospital</name>
      <address>
        <city>Dar es Salaam</city>
        <zip>65439</zip>
        <country>Tanzania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hussein L Kidanto, MD, PhD</last_name>
      <phone>+255 748 462478</phone>
      <email>hkidanto@yahoo.co.uk</email>
    </contact>
    <investigator>
      <last_name>Hussein L Kidanto, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Tanzania</country>
  </location_countries>
  <verification_date>November 2016</verification_date>
  <lastchanged_date>November 19, 2016</lastchanged_date>
  <firstreceived_date>June 1, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
